W. H. Martin

发表

The Use of β,γ-Methyleneadenosine 5′-Triphosphate to Determine ATP Competition in a Scintillation Proximity Kinase Assay

R. Spencer, M. Peterson, W. H. Martin, 1999 .

A simple and robust cell-based assay for the discovery of novel cytokinesis inhibitors

G. Rumbaugh, P. Griffin, T. Vaissiere, 2020, bioRxiv.

Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease.

Ping Chen, D. Kitchen, C. Cywin, 2015, Journal of medicinal chemistry.

Design, Synthesis, and Evaluation of Nonretinoid Retinol Binding Protein 4 Antagonists for the Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease

Ping Chen, D. Kitchen, C. Cywin, 2014, Journal of medicinal chemistry.

On the mechanism by which dicyclohexylcarbodiimide and quinine inhibit K+ transport in rat liver mitochondria.

D. Diresta, W. H. Martin, A. Beavis, 1986, The Journal of biological chemistry.

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

J. O’Shea, A. Milici, B. Reitz, 2003, Science.

Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.

Carolyn B Levy, R. McPherson, J. Treadway, 1998, Diabetes.

Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis.

Ping Chen, D. Kitchen, W. Blaner, 2019, Journal of medicinal chemistry.

Interactions of the Complex Secretory Vesicle Binding Protein Chromobindin A with Nucleotides

W. H. Martin, C. Creutz, 1990, Journal of neurochemistry.

CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases*

Christopher S. Poss, J. Kath, W. Brissette, 2003, Journal of Biological Chemistry.

Chromobindin A, a Ca2+- and ATP-dependent chromaffin granule-binding protein, is found in a variety of tissues and in yeast.

W. H. Martin, C. Creutz, E. Fromer, 1989, Biochemical and biophysical research communications.

Kinetics of inhibition and binding of dicyclohexylcarbodiimide to the 82,000-dalton mitochondrial K+/H+ antiporter.

D. Diresta, W. H. Martin, K. Garlid, 1986, The Journal of biological chemistry.

The Roles of Ca2+Dependent Membrane-Binding Proteins in the Regulation and Mechanism of Exocytosis

W. H. Martin, C. Creutz, H. C. Hamman, 1987 .

Potent small molecule CCR1 antagonists.

Christopher S. Poss, J. Kath, W. Brissette, 2004, Bioorganic & medicinal chemistry letters.

The discovery of structurally novel CCR1 antagonists derived from a hydroxyethylene peptide isostere template.

J. Kath, R. Gladue, W. H. Martin, 2004, Bioorganic & medicinal chemistry letters.

Chromobindin A. A Ca2+ and ATP regulated chromaffin granule binding protein.

W. H. Martin, C. Creutz, 1987, The Journal of biological chemistry.

Rational design, synthesis, and X-ray structure of renin inhibitors with extended P1 sidechains

M. Ammirati, D. Danley, G. Schulte, 1995 .

Characterization of Calcium‐Dependent Chromaffin Granule Binding Proteins

W. H. Martin, C. Creutz, H. C. Hamman, 1987 .

CHARACTERIZATION OF CALCIUM-DEPENDENT CHROMAFFIN GRANULE-BINDING PROTEINS1

S. Parsons, W. H. Martin, C. Creutz, 1987 .

Identification of an 82,000-dalton protein responsible for K+/H+ antiport in rat liver mitochondria.

W. H. Martin, A. Beavis, K. Garlid, 1984, The Journal of biological chemistry.

Isozyme-nonselective N-Substituted Bipiperidylcarboxamide Acetyl-CoA Carboxylase Inhibitors Reduce Tissue Malonyl-CoA Concentrations, Inhibit Fatty Acid Synthesis, and Increase Fatty Acid Oxidation in Cultured Cells and in Experimental Animals*

D. Hargrove, D. Dalvie, J. Chapman, 2003, Journal of Biological Chemistry.

Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.

D. Danley, R. McPherson, J. Treadway, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Identification of chromaffin granule-binding proteins. Relationship of the chromobindins to calelectrin, synhibin, and the tyrosine kinase substrates p35 and p36.

K. Gould, S. Parsons, S. Crane, 1987, The Journal of biological chemistry.

Benzimidazolone p38 inhibitors.

C. Gabel, T. Carty, John T Barberia, 2004, Bioorganic & medicinal chemistry letters.

NanoStore: A Concept for Logistical Improvements of Compound Handling in High-Throughput Screening

Jeremy R Everett, Philip Gribbon, Neil Benson, 2005, Journal of biomolecular screening.

A novel series of non-carboxylic acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and congeners.

P. Oates, J. Coutcher, M. O’Gorman, 2005, Journal of Medicinal Chemistry.

A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran- 2-sulfonyl)-2-H-pyridazin-3-one.

P. Oates, J. Coutcher, M. O’Gorman, 2003, Journal of medicinal chemistry.

Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase.

R. McPherson, J. Treadway, E. M. Gibbs, 1998, Journal of medicinal chemistry.

Site-directed double fluorescent tagging of human renin and collagenase (MMP-1) substrate peptides using the periodate oxidation of N-terminal serine. An apparently general strategy for provision of energy-transfer substrates for proteases.

K. Geoghegan, A. Mccoll, G. Daumy, 1993, Bioconjugate chemistry.

G. Cole, J. Baudier, P. Timiras, 1988, Neurochemistry International.